GSK plc: Despite its challenges, GSK remains investable

Published on 2025-05-21 at 10:08

Alphavalue

This Alphavalue article, the European leader in independent research, is only available to subscribers .

Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about GSK plc

US FDA advisers recommend against Otsuka's PTSD combination treatment	07-18	RE
Health Care Declines as Traders Hedge on Growth Views - Health Care Roundup	07-18	DJ
European shares end flat as markets assess earnings flurry	07-18	RE
European shares end flat as markets assess earnings flurry	07-18	RE
FTSE 100 logs fourth straight week of gains on rate cut optimism, earnings	07-18	RE
FTSE 100 logs fourth straight week of gains on rate cut optimism, earnings	07-18	RE
European Equities Close Mixed in Friday Trading; Markets End Week on Muted Note	07-18	MT
Top Midday Stories: Netflix Shares Fall Despite Earnings Beat; Chevron Completes Acquisition of Hess After Winning Legal Dispute With Exxon	07-18	MT
FTSE 100 Closes Week Higher Amid Trading Updates, M&A	07-18	MT
Stocks end in green, US housing completions drop	07-18	AN
GSK plc Provides Update on US FDA Advisory Committee Review of Blenrep (belantamab Mafodotin-blmf) Combinations	07-18	CI
There's joy in the air	07-18
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Strong Economic Data	07-18	MT
FTSE 100 gain tempered as GSK tanks	07-18	AN
GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt	07-18	DJ
GSK Says US FDA Committee Votes Against Blood Cancer Drug's Benefit-Risk Profile; Shares Down Pre-Bell	07-18	MT
GSK: FDA advisory committee turns down Blenrep	07-18
GSK falls as blood cancer drug likely headed for US rejection	07-18	RE
GSK falls as blood cancer drug likely headed for US rejection	07-18	RE
FTSE 100 edges up; Reckitt rises on home care sale	07-18	AN
GSK : Berenberg gives a Neutral rating	07-18	ZD
Joy in the Air	07-18
Setback for GSK as Blenrep does not win US FDA committee support	07-18	AN
GSK : JP Morgan gives a Sell rating	07-18	ZD
US FDA Committee Advises Against Blenrep Combinations for Myeloma	07-17	MT